Richard Becker, MD
Radiology & Biomedical Imaging
Titles
- Staff Affiliate - Other
Education & Training
- MDNew York Medical College (1979)
Additional Information
Board Certifications
- AB of Radiology, Diagnostic Radiology (1984)
Publications
- Harrington J, Hellkamp A, Mahaffey K, Breithardt G, Halperin J, Hankey G, Becker R, Nessel C, Berkowitz S, Fox K, Singer D, Goodman S, Patel M, Piccini J. Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal Of The American Heart Association 2024, e028951. PMID: 38780169, DOI: 10.1161/jaha.122.028951.
- Ali A, Becker R. Factor XI: structure, function and therapeutic inhibition. Journal Of Thrombosis And Thrombolysis 2024, 1-14. PMID: 38622277, DOI: 10.1007/s11239-024-02972-5.
- Eggers K, Batra G, Lindahl B, Lakic T, Lindbäck J, Budaj A, Cornel J, Giannitsis E, Katus H, Storey R, Becker R, Siegbahn A, Wallentin L. Temporal biomarker concentration patterns during the early course of acute coronary syndrome. Clinical Chemistry And Laboratory Medicine 2024, 62: 1167-1176. PMID: 38341860, DOI: 10.1515/cclm-2023-1253.
- Ueland T, Åkerblom A, Ghukasyan T, Michelsen A, Aukrust P, Becker R, Bertilsson M, Himmelmann A, James S, Siegbahn A, Storey R, Kontny F, Wallentin L. Abstract 12851: Osteoprotegerin is Associated With Major Bleeding but Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes - Insights From the PLATelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation 2016, 134 DOI: 10.1161/circ.134.suppl_1.12851.
- Piccini J, Stevens S, Lokhnygina Y, Patel M, Singer D, Halperin J, Hankey G, Hacke W, Becker R, Nessel C, Mahaffey K, Fox K, Califf R, Breithardt G. Abstract 19281: Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial. Circulation 2012, 126 DOI: 10.1161/circ.126.suppl_21.a19281.
- Piccini J, Stevens S, Patel M, Mahaffey K, Paolini J, Nessel C, Becker R, Halperin J, Hacke W, Singer D, Hankey G, Breithardt G, Fox K, Califf R. Abstract 17137: Renal Dysfunction is a Potent Predictor of Stroke and Systemic Embolism Among Individuals with Atrial Fibrillation: Results from the ROCKET AF Trial. Circulation 2011, 124 DOI: 10.1161/circ.124.suppl_21.a17137.
- Ahrens I, Putz V, Zelenkosfke S, Moser M, Povsic T, Alexander J, Becker R, Rusconi C, Bode C. Abstract 9771: Reg1, a Novel RNA-Aptamer Direct Factor IXa-inhibitor (pegnivacogin) Reduces Platelet Activation in Healthy Volunteers and Residual Platelet Aggregation in Patients with ACS. A Radar Substudy. Circulation 2011, 124 DOI: 10.1161/circ.124.suppl_21.a9771.
- Goodman S, Wojdyla D, White H, Piccini J, Paolini J, Nessel C, Mahaffey K, Patel M, Becker R, Halperin J, Hacke W, Singer D, Hankey G, Breithardt G, Fox K, Califf R. Abstract 16903: Predictors of Major Bleeding Risk: Insights from the Rivaroxaban Once-Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Circulation 2011, 124 DOI: 10.1161/circ.124.suppl_21.a16903.
Departments and Programs
Titles
- Staff Affiliate - Other
Education & Training
- MDNew York Medical College (1979)
Additional Information
Board Certifications
- AB of Radiology, Diagnostic Radiology (1984)
Publications
- Harrington J, Hellkamp A, Mahaffey K, Breithardt G, Halperin J, Hankey G, Becker R, Nessel C, Berkowitz S, Fox K, Singer D, Goodman S, Patel M, Piccini J. Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis. Journal Of The American Heart Association 2024, e028951. PMID: 38780169, DOI: 10.1161/jaha.122.028951.
- Ali A, Becker R. Factor XI: structure, function and therapeutic inhibition. Journal Of Thrombosis And Thrombolysis 2024, 1-14. PMID: 38622277, DOI: 10.1007/s11239-024-02972-5.
- Eggers K, Batra G, Lindahl B, Lakic T, Lindbäck J, Budaj A, Cornel J, Giannitsis E, Katus H, Storey R, Becker R, Siegbahn A, Wallentin L. Temporal biomarker concentration patterns during the early course of acute coronary syndrome. Clinical Chemistry And Laboratory Medicine 2024, 62: 1167-1176. PMID: 38341860, DOI: 10.1515/cclm-2023-1253.
- Ueland T, Åkerblom A, Ghukasyan T, Michelsen A, Aukrust P, Becker R, Bertilsson M, Himmelmann A, James S, Siegbahn A, Storey R, Kontny F, Wallentin L. Abstract 12851: Osteoprotegerin is Associated With Major Bleeding but Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes - Insights From the PLATelet Inhibition and Patient Outcomes (PLATO) Trial. Circulation 2016, 134 DOI: 10.1161/circ.134.suppl_1.12851.
- Piccini J, Stevens S, Lokhnygina Y, Patel M, Singer D, Halperin J, Hankey G, Hacke W, Becker R, Nessel C, Mahaffey K, Fox K, Califf R, Breithardt G. Abstract 19281: Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial. Circulation 2012, 126 DOI: 10.1161/circ.126.suppl_21.a19281.
- Piccini J, Stevens S, Patel M, Mahaffey K, Paolini J, Nessel C, Becker R, Halperin J, Hacke W, Singer D, Hankey G, Breithardt G, Fox K, Califf R. Abstract 17137: Renal Dysfunction is a Potent Predictor of Stroke and Systemic Embolism Among Individuals with Atrial Fibrillation: Results from the ROCKET AF Trial. Circulation 2011, 124 DOI: 10.1161/circ.124.suppl_21.a17137.
- Ahrens I, Putz V, Zelenkosfke S, Moser M, Povsic T, Alexander J, Becker R, Rusconi C, Bode C. Abstract 9771: Reg1, a Novel RNA-Aptamer Direct Factor IXa-inhibitor (pegnivacogin) Reduces Platelet Activation in Healthy Volunteers and Residual Platelet Aggregation in Patients with ACS. A Radar Substudy. Circulation 2011, 124 DOI: 10.1161/circ.124.suppl_21.a9771.
- Goodman S, Wojdyla D, White H, Piccini J, Paolini J, Nessel C, Mahaffey K, Patel M, Becker R, Halperin J, Hacke W, Singer D, Hankey G, Breithardt G, Fox K, Califf R. Abstract 16903: Predictors of Major Bleeding Risk: Insights from the Rivaroxaban Once-Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Circulation 2011, 124 DOI: 10.1161/circ.124.suppl_21.a16903.
Departments and Programs